These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1069550)

  • 1. Discussion paper: effect of hemolytic streptococci on lymphocytic leukemia in AKR mice.
    Havas HF
    Ann N Y Acad Sci; 1976; 277(00):299-301. PubMed ID: 1069550
    [No Abstract]   [Full Text] [Related]  

  • 2. BCG in cancer immunotherapy: experimental and clinical trials of its use in treatment of leukemia minimal and or residual disease.
    Mathé G; Weiner R; Pouillart P; Schwarzenberg L; Jasmin C; Schneider M; Hayat M; Amiel JL; de Vassal F; Rosenfeld C
    Natl Cancer Inst Monogr; 1973 Dec; 39():165-75. PubMed ID: 4595314
    [No Abstract]   [Full Text] [Related]  

  • 3. Discussion paper: experimental and clinical immunopharmacology data applicable to cancer immunotherapy.
    Mathé G; Schwarzenberg L; Halle-Pannenko O; Simmler MC
    Ann N Y Acad Sci; 1976; 277(00):467-84. PubMed ID: 826207
    [No Abstract]   [Full Text] [Related]  

  • 4. BCG immunization for the lymphoid leukemia line (LSTRA) in CDF1 mice.
    Chaparas SD; Chirigos M; Pearson J; Sher N
    Natl Cancer Inst Monogr; 1973 Dec; 39():87-8. PubMed ID: 4595328
    [No Abstract]   [Full Text] [Related]  

  • 5. Alloimmunization and adoptive immunotherapy of leukemia.
    Truitt RL; Shih CY; Rimm AA; Tempelis LD; Bortin MM
    Transplant Proc; 1981 Dec; 13(4):1910-4. PubMed ID: 6949385
    [No Abstract]   [Full Text] [Related]  

  • 6. Prolonged survival in long-passage AKR leukemia using chemotherapy, radiotherapy, and adoptive immunotherapy.
    Bortin MM; Rimm AA; Rodey GE; Giller R; Saltzstein EC
    Cancer Res; 1974 Aug; 34(8):1851-6. PubMed ID: 4152270
    [No Abstract]   [Full Text] [Related]  

  • 7. Prophylactic therapy of spontaneous leukemia in AKR mice by polyadenylic-polyuridylic acid.
    Drake WP; Cimino EF; Mardiney MR; Sutherland JC
    J Natl Cancer Inst; 1974 Mar; 52(3):941-4. PubMed ID: 4596992
    [No Abstract]   [Full Text] [Related]  

  • 8. Graft versus leukemia: quantification of adoptive immunotherapy in murine leukemia.
    Bortin MM; Rimm AA; Saltzstein EC
    Science; 1973 Feb; 179(4075):811-3. PubMed ID: 4405359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined drug and immunostimulation therapy against a syngeneic murine leukemia.
    Pearson JW; Chirigos MA; Chaparas SD; Sher NA
    J Natl Cancer Inst; 1974 Feb; 52(2):463-8. PubMed ID: 4593139
    [No Abstract]   [Full Text] [Related]  

  • 10. Allogeneic bone marrow chimerism in germfree mice. 3. Therapy of leukemic AKR mice.
    Truitt RL; Pollard M; Srivastava KK
    Proc Soc Exp Biol Med; 1974 May; 146(1):153-8. PubMed ID: 4597165
    [No Abstract]   [Full Text] [Related]  

  • 11. Graft versus leukemia. VIII. Selective reduction in antihost reactivity without loss of antileukemic reactivity by treatment of donor mice with lipopolysaccharide.
    Truitt RL; Rose WC; Rimm AA; Bortin MM
    Exp Hematol; 1978 May; 6(5):488-98. PubMed ID: 26584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunology and immunotherapy of leukemia (basic results of 8-years research)].
    Bergol'ts VM
    Vopr Onkol; 1978; 24(11):16-24. PubMed ID: 283626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoadjuvant treatment of primary grafted and spontaneous AKR-leukemia. I. Treatment efficiency correlated to autoimmune reactivity.
    Olsson L; Ebbesen P
    J Immunol; 1979 Mar; 122(3):772-80. PubMed ID: 376705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy in the treatment of acute leukaemia.
    Whittaker JA
    Br J Haematol; 1980 Jun; 45(2):187-93. PubMed ID: 6934004
    [No Abstract]   [Full Text] [Related]  

  • 15. Repetitive administration of BCG in prevention and treatment of spontaneous leukemia of AKR mice.
    Ungaro PC; Drake WP; Mardiney MR
    J Natl Cancer Inst; 1973 Jan; 50(1):125-8. PubMed ID: 4692859
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of three strains of BCG against a murine leukemia after drug therapy.
    Sher NA; Pearson JW; Chaparas SD; Chirigos MA
    J Natl Cancer Inst; 1973 Dec; 51(6):2001-3. PubMed ID: 4587756
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunoprophylaxis and treatment of leukemia in AKR mice: repetitive use of BCG.
    Mardiney MR; Ungaro PC; Drake WP
    Natl Cancer Inst Monogr; 1973 Dec; 39():89-90. PubMed ID: 4595329
    [No Abstract]   [Full Text] [Related]  

  • 18. Active immunotherapy of AkR mice spontaneous leukemia.
    Mathé G; Halle-Pannenko O; Bourut C
    Rev Eur Etud Clin Biol; 1972 Dec; 17(10):997-1000. PubMed ID: 4660002
    [No Abstract]   [Full Text] [Related]  

  • 19. Attempts at immunotherapy of 100 patients with acute lymphoid leukemia: some factors influencing results.
    Mathé G; Pouillart P; Schwarzenberg L; Amiel JL; Schneider M; Hayat M; De Vassal F; Jasmin C; Rosenfeld C; Weiner R; Rappaport H
    Natl Cancer Inst Monogr; 1972 Dec; 35():361-72. PubMed ID: 4512322
    [No Abstract]   [Full Text] [Related]  

  • 20. Active immunotherapy in the treatment of experimental leukemias and acute lymphoblastic leukemia in man.
    Mathé G; Hayat M; Amiel JL; Schwarzenberg L; Schneider M; Pouillart P; Cattan A
    Boll Ist Sieroter Milan; 1971; 50(4):251-9. PubMed ID: 5293498
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.